1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      A peripheral signature of Alzheimer’s disease featuring microbiota-gut-brain axis markers

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Background

          Increasing evidence links the gut microbiota (GM) to Alzheimer’s disease (AD) but the mechanisms through which gut bacteria influence the brain are still unclear. This study tests the hypothesis that GM and mediators of the microbiota-gut-brain axis (MGBA) are associated with the amyloid cascade in sporadic AD.

          Methods

          We included 34 patients with cognitive impairment due to AD (CI-AD), 37 patients with cognitive impairment not due to AD (CI-NAD), and 13 cognitively unimpaired persons (CU). We studied the following systems: (1) fecal GM, with 16S rRNA sequencing; (2) a panel of putative MGBA mediators in the blood including immune and endothelial markers as bacterial products (i.e., lipopolysaccharide, LPS), cell adhesion molecules (CAMs) indicative of endothelial dysfunction (VCAM-1, PECAM-1), vascular changes (P-, E-Selectin), and upregulated after infections (NCAM, ICAM-1), as well as pro- (IL1β, IL6, TNFα, IL18) and anti- (IL10) inflammatory cytokines; (3) the amyloid cascade with amyloid PET, plasma phosphorylated tau (pTau-181, for tau pathology), neurofilament light chain (NfL, for neurodegeneration), and global cognition measured using MMSE and ADAScog. We performed 3-group comparisons of markers in the 3 systems and calculated correlation matrices for the pooled group of CI-AD and CU as well as CI-NAD and CU. Patterns of associations based on Spearman’s rho were used to validate the study hypothesis.

          Results

          CI-AD were characterized by (1) higher abundance of Clostridia_UCG-014 and decreased abundance of Moryella and Blautia ( p < .04); (2) elevated levels of LPS ( p < .03), upregulation of CAMs, Il1β, IL6, and TNFα, and downregulation of IL10 ( p < .05); (3) increased brain amyloid, plasma pTau-181, and NfL ( p < 0.004) compared with the other groups. CI-NAD showed (1) higher abundance of [Eubacterium] coprostanoligenes group and Collinsella and decreased abundance of Lachnospiraceae_ND3007_group, [Ruminococcus]_gnavus_group and Oscillibacter ( p < .03); (2) upregulation of PECAM-1 and TNFα ( p < .03); (4) increased plasma levels of NfL ( p < .02) compared with CU. Different GM genera were associated with immune and endothelial markers in both CI-NAD and CI-AD but these mediators were widely related to amyloid cascade markers only in CI-AD.

          Conclusions

          Specific bacterial genera are associated with immune and endothelial MGBA mediators, and these are associated with amyloid cascade markers in sporadic AD. The physiological mechanisms linking the GM to the amyloid cascade should be further investigated to elucidate their potential therapeutic implications.

          Supplementary Information

          The online version contains supplementary material available at 10.1186/s13195-023-01218-5.

          Related collections

          Most cited references65

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          Metagenomic biomarker discovery and explanation

          This study describes and validates a new method for metagenomic biomarker discovery by way of class comparison, tests of biological consistency and effect size estimation. This addresses the challenge of finding organisms, genes, or pathways that consistently explain the differences between two or more microbial communities, which is a central problem to the study of metagenomics. We extensively validate our method on several microbiomes and a convenient online interface for the method is provided at http://huttenhower.sph.harvard.edu/lefse/.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Interactions between the microbiota and the immune system.

            The large numbers of microorganisms that inhabit mammalian body surfaces have a highly coevolved relationship with the immune system. Although many of these microbes carry out functions that are critical for host physiology, they nevertheless pose the threat of breach with ensuing pathologies. The mammalian immune system plays an essential role in maintaining homeostasis with resident microbial communities, thus ensuring that the mutualistic nature of the host-microbial relationship is maintained. At the same time, resident bacteria profoundly shape mammalian immunity. Here, we review advances in our understanding of the interactions between resident microbes and the immune system and the implications of these findings for human health.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The Role of Short-Chain Fatty Acids From Gut Microbiota in Gut-Brain Communication

              A substantial body of evidence supports that the gut microbiota plays a pivotal role in the regulation of metabolic, endocrine and immune functions. In recent years, there has been growing recognition of the involvement of the gut microbiota in the modulation of multiple neurochemical pathways through the highly interconnected gut-brain axis. Although amazing scientific breakthroughs over the last few years have expanded our knowledge on the communication between microbes and their hosts, the underpinnings of microbiota-gut-brain crosstalk remain to be determined. Short-chain fatty acids (SCFAs), the main metabolites produced in the colon by bacterial fermentation of dietary fibers and resistant starch, are speculated to play a key role in neuro-immunoendocrine regulation. However, the underlying mechanisms through which SCFAs might influence brain physiology and behavior have not been fully elucidated. In this review, we outline the current knowledge about the involvement of SCFAs in microbiota-gut-brain interactions. We also highlight how the development of future treatments for central nervous system (CNS) disorders can take advantage of the intimate and mutual interactions of the gut microbiota with the brain by exploring the role of SCFAs in the regulation of neuro-immunoendocrine function.
                Bookmark

                Author and article information

                Contributors
                mmarizzoni@fatebenefratelli.eu
                Journal
                Alzheimers Res Ther
                Alzheimers Res Ther
                Alzheimer's Research & Therapy
                BioMed Central (London )
                1758-9193
                31 May 2023
                31 May 2023
                2023
                : 15
                : 101
                Affiliations
                [1 ]GRID grid.419422.8, Laboratory of Biological Psychiatry, , IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, ; Brescia, Italy
                [2 ]GRID grid.419422.8, Laboratory of Neuroimaging and Alzheimer’s Epidemiology, , IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, ; Brescia, Italy
                [3 ]IRCCS SYNLAB SDN, Naples, Italy
                [4 ]GRID grid.4708.b, ISNI 0000 0004 1757 2822, Department of Pharmacological and Biomolecular Sciences, , University of Milan, ; Milan, Italy
                [5 ]GRID grid.429699.9, ISNI 0000 0004 1790 0507, Istituto Di Biostrutture E Bioimmagini (I.B.B.) - CNR, ; Naples, Italy
                [6 ]GRID grid.4691.a, ISNI 0000 0001 0790 385X, Dip.to Di Scienze Chimiche, , Università Degli Studi Di Napoli - Federico II, ; Naples, Italy
                [7 ]GRID grid.8591.5, ISNI 0000 0001 2322 4988, Genetic Medicine Division, , University Hospitals and University of Geneva, ; Geneva, Switzerland
                [8 ]GRID grid.8591.5, ISNI 0000 0001 2322 4988, Memory Clinic and LANVIE - Laboratory of Neuroimaging of Aging, , University Hospitals and University of Geneva, ; Geneva, Switzerland
                Article
                1218
                10.1186/s13195-023-01218-5
                10230724
                37254223
                b7708d1b-a07c-4bdc-a009-73268420dafe
                © The Author(s) 2023

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

                History
                : 2 August 2022
                : 21 March 2023
                Categories
                Research
                Custom metadata
                © BioMed Central Ltd., part of Springer Nature 2023

                Neurology
                cognitive impairment,alzheimer’s disease,gut microbiota,microbiota-gut-brain axis,lipopolysaccharide,endothelial dysfunction

                Comments

                Comment on this article